Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
70 Leser
Artikel bewerten:
(0)

Clariant AG: Clariant to be included in SPI Select Dividend 20 Index

Clariant AG / Clariant to be included in SPI® Select Dividend 20 Index . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

                                                           

  • Clariant to be listed among the 20 highest-yielding stocks in the SPI index
  • Positive result of meeting target to increase or at least maintain dividends
  • The dividend is an important component of our shareholder value proposition
 
 

Muttenz, March 17, 2017 - Clariant, a world leader in specialty chemicals, will be included in the SPI Select Dividend 20 Index basket. The index will be adjusted on 17 March 2017 after closing. The adjustment takes effect on 20 March 2017.

"Increasing operating cash flow is clearly emphasized by Clariant's strategy. As the 2016 results have demonstrated, one aim of our cash generation is to return value to shareholders as well," explains CEO Hariolf Kottmann. "We are proud that our efforts to create long-term added value for all of our stakeholders are recognized by this industry benchmark."

The SPI Select Dividend 20 Index includes the 20 stocks which represent the highest-yielding companies with a stable dividend paying record and solid profitability from all stocks in the SPI index. The weight of each constituent is based on the free float market capitalization and the normalized dividend yield calculated at the annual index review. Additionally, the weight of each security is subject to a 15% capping factor calculated and applied quarterly. The component rebalancing is implemented yearly on the ordinary review of March.

Corporate Media Relations Investor Relations
Jochen Dubiel

Phone +41 61 469 63 63
jochen.dubiel@clariant.com
Anja Pomrehn

Phone +41 61 469 67 45
anja.pomrehn@clariant.com
Thijs Bouwens

Phone +41 61 469 63 63
thijs.bouwens@clariant.com
Maria ivek

Phone +41 61 469 62 92
maria.ivek@clariant.com
Follow us on Twitter (https://twitter.com/clariant), Facebook (https://www.facebook.com/Clariant-146077545551792/timeline/), Google Plus (https://plus.google.com/b/116352333100637793636/116352333100637793636/posts), LinkedIn (https://www.linkedin.com/company/clariant?trk=top_nav_home).

 

 
 

Press Release german (http://hugin.info/100166/R/2088357/788365.pdf)
Press Release english (http://hugin.info/100166/R/2088357/788364.pdf)


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Clariant AG via Globenewswire

--- End of Message ---

Clariant AG
Rothausstrasse 61 Muttenz 1 Switzerland

ISIN: CH0012142631;


Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.